HTN Lunch & Learn: Payer Strategies for GLP-1 Medications with Deana Bell & Mark Gruenhaupt
GLP-1 prescriptions for obesity treatment has been a widely discussed topic across the healthcare industry - from startups building companies in the space to providers prescribing it to their patients to payers weighing the benefit of reimbursement for the blockbuster drug.
Following the increasing proof of efficacy to treat obesity and the growing consumer demand, payers are more seriously having to consider reimbursement strategies to appropriately manage the opportunities and challenges.
The Milliman team put together this framework to help payers think through care management, medication counseling & education, and more. We'll be joined by two of the articles co-authors, Deana Bell (Principal & Consulting Actuary) and Mark Gruenhaupt (Senior Pharmacy Management Consultant), who will walk us through the framework and answer audience questions.
We're excited to see you there!
